Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123838033 | 12383803 | 3 | F | 20160505 | 20160711 | 20160519 | 20160718 | EXP | US-ALEXION PHARMACEUTICALS INC-A201603496 | ALEXION | 69.00 | YR | M | Y | 0.00000 | 20160718 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123838033 | 12383803 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 900 MG, Q2W | 10800 | MG | N | 125166 | 900 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | QOW | |||
| 123838033 | 12383803 | 2 | C | NEUPOGEN | FILGRASTIM | 1 | Subcutaneous | 300 MG, TIW | 0 | 300 | MG | TIW | |||||||
| 123838033 | 12383803 | 3 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Oral | 1000 ?G, QD | 0 | 1000 | UG | QD | |||||||
| 123838033 | 12383803 | 4 | C | EXJADE | DEFERASIROX | 1 | Oral | 500 MG 4 TABLETS, QD | 0 | 500 | MG | QD | |||||||
| 123838033 | 12383803 | 5 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | Oral | 81 MG, QD | 0 | 81 | MG | QD | |||||||
| 123838033 | 12383803 | 6 | C | HYDROCODONE | HYDROCODONE | 1 | Oral | 32 MG, EVERY 6 HOURS AS NEEDED | 0 | 32 | MG | ||||||||
| 123838033 | 12383803 | 7 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 325 MG, EVERY 6 HOURS AS NEEDED | 0 | 325 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123838033 | 12383803 | 1 | Paroxysmal nocturnal haemoglobinuria |
| 123838033 | 12383803 | 2 | Myelodysplastic syndrome |
| 123838033 | 12383803 | 3 | Anaemia |
| 123838033 | 12383803 | 4 | Haemochromatosis |
| 123838033 | 12383803 | 5 | Product used for unknown indication |
| 123838033 | 12383803 | 6 | Pain |
| 123838033 | 12383803 | 7 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123838033 | 12383803 | HO |
| 123838033 | 12383803 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123838033 | 12383803 | Asthenia | |
| 123838033 | 12383803 | Malaise | |
| 123838033 | 12383803 | Pyrexia | |
| 123838033 | 12383803 | Scrotal abscess |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123838033 | 12383803 | 1 | 20151106 | 20160421 | 0 |